Associate Professor Andrew Rowland

I am passionate about ensuring that oncology patients achieve optimal therapeutic outcomes, teaching young clinicians and scientists and being a role model for courage, humility, loyalty and perseverence to my two sons.

I was awarded a PhD in Clinical Pharmacology from Flinders University in 2009, then spent two years as a post-doctoral researcher in the Miners' Drug Metabolism laboratory. In 2011 I was appointed to my current academic position in the College of Medicine and Public Health. Now Associate Professor, and as a Beat Cancer Mid-Career Research Fellow, I am a leader of the Precision Medicine Group here at Flinders. In this role I lead a dynamic team of scientists and students undertaking cutting edge research in the fields of precision oncology and exosome derived biomarkers of drug exposure.

I teach the core principles of pharmacology and therapeutics to a spectrum of medical and health professionals including doctors, nurse prescribers, paramedics and medical scientists. My research focus is the advancement of precision medicine approaches such that they translate to direct improvements for cancer patients by facilitating the maximal therapeutic benefit from targeted anti-cancer medicines, while minimising the harmful effects of these drugs. I believe that success requires commitment, hard work, knowledge, research and being true to your word.

I am an analytical chemist with a research focus on translating pharmacokinetic principles into clinical practice through the optimization of drug dosing, with a specific interest in precision dosing of anti-cancer drugs to achieve optimal therapeutic outcomes for oncology patients.

The research techniques that I apply to achieve this include:

• Clinical trials: patient and healthy volunteer
• Molecular biology: Exosome isolation and characterization
• Analytical chemistry and proteomics
• Biostatistics
• PBPK modelling and simulation